Press Releases | BioSenic

Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

Read more about Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

Read more about Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 26 February 2021

Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 26 February 2021

Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference

Read more about Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference

Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer

Read more about Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer

Bone Therapeutics announces 2020 full year results

Read more about Bone Therapeutics announces 2020 full year results

Bone Therapeutics to host Annual General Meeting on 9 June 2021

Read more about Bone Therapeutics to host Annual General Meeting on 9 June 2021

Bone Therapeutics to participate in upcoming conferences

Read more about Bone Therapeutics to participate in upcoming conferences

Bone Therapeutics Provides First Quarter 2021 Business Update

Read more about Bone Therapeutics Provides First Quarter 2021 Business Update

Bone Therapeutics announces Annual General Meeting results

Read more about Bone Therapeutics announces Annual General Meeting results

Subscribe to Press Releases